What's breaking now, across thousands of outlets.
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) said it targets to generate $6-7 billion in innovative medicines revenue by 2030. The company projects innovative gross margins target of above 75%, with the mix shift driving margin expansion.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
KUALA LUMPUR: Empire Premium Food Bhd, the owner-operator behind Malaysia’s largest sushi chain Empire Sushi, saw its net profits increase 26.3 per cent quarter-on-quarter to RM13.7 million for the…
SoFi's record earnings and unconventional banking strategy reveal a compelling growth opportunity. But rising funding costs could change the equation. Here's what investors need to watch.
History repeatedly shows Washington has had mixed success in preventing Iran from acquiring or locally producing portable, easily concealable shoulder-fired missiles.
(RTTNews) - A rally in global stock markets powered by the surge in technology shares helped the CAC 40 index to extend its winning streak.
